acta diurna · run record
2026-09-05-medtech
5 September 2026 ·partial
| # | stage | model | verdict | retries | notes | cost |
|---|---|---|---|---|---|---|
| 01 | nuncio | deepseek/deepseek-v4-flash | — | — | rss:FierceBiotech failed (Cannot convert object to primitive value) [optional] | rss:Fierce Pharma failed (Cannot convert object to primitive value) [optional] | 3 gathered stories already covered by the Specola — excluded: "STAT+: Seattle scientists launch $95 million AI biology effort", "STAT+: OpenEvidence launches new family of AI models", "STAT+: Ionis wins FDA approval for first drug for Alexander disease, a rare and deadly neurological disorder" | $0.0003 |
| 02 | bulletins | anthropic/claude-sonnet-5 | — | — | "Recipients of gene-edited pig kidneys successfully receive human organs": pass (0 redispatch) | "FDA approves first drug to treat Alexander disease": spiked (2 redispatch) | $0.0512 |
| 03 | dispatch | — | — | — | only 1 bulletins survived the gates — below quiet-day threshold; no dispatch | — |
| 04 | spikes | — | — | — | SPIKED "FDA approves first drug to treat Alexander disease": The underlying FDA citation does not resolve, so the claimed approval cannot be verified against the purported primary announcement.; The bulletin calls Alexander disease "rare," but the supplied source material supports only that it is fatal, neurological, and genetic; it does not support the rarity claim. | — |
| the day's wage | $0.0514 | |||||